Global Antacids Market will reach US$ 10.50 Billion in 2027 according to the publisher. Globally, antacids are widely used for treating ulcers, inflammation, dyspepsia discomfort, sore stomach, stomach acid indigestion, and stomach upset. It is an over-the-counter (OTC) medication that neutralizes the acid in the stomach to relieve indigestion and heartburn. Further, they contain ingredients like magnesium hydroxide, sodium bicarbonate, calcium, and aluminum are commonly available in convenient chewable powder, tablets, and liquid forms. They are self-prescribed medications and act by neutralizing the acid in the stomach and inhibiting pepsin.Global Antacids Market will reach US$ 10.50 Billion in 2027. Industry Trends By Product, Application, End User, Impact of Inflation, Company Analysis, Global Forecast 2023-2027
Antacids Market Size is likely to expand at a CAGR of 3.78 % during 2022 - 2027:
The development in the antacids market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had prior led to restrictive containment measures involving remote working, social distancing, and the closure of commercial activities that resulted in operational challenges.Poor lifestyle adoptions such as deskbound jobs, poor sleep quality, and irregular dietary habits, which increases the acidity level of the stomach and lead to gastroesophageal reflux disease, are essential drivers for the evolution of the antacids market. As per the American College of Gastroenterology, about 60 million Americans suffer from gastroesophageal reflux disease.
Tablets are Expected to Hold a Major Market Share:
By Dosage Form, Tablet was estimated to be the largest segment. Chewable tablets in different flavors help improve patient adherence to the medication, which in turn is expected to contribute to the segment's growth. In addition, tablets are easy to store and can provide the exact dosage amount to the patients compared to the other dosage forms. According to our research findings Antacids Market Size is likely to expand at a CAGR of 3.78% during 2022 - 2027.Distribution Channel Insights:
By distribution channel, the market is trifurcated into retail pharmacies, online pharmacies, and hospital pharmacies. Online pharmacy is the fastest-growing segment over the forecast period due to increasing consumer awareness. In addition, people are picking online pharmacies due to lucrative offers, such as price discounts, ease in the availability of drugs, and home delivery services. Furthermore, the increasing adoption of information technology in the healthcare sector aids clinicians in sending prescriptions electronically, which is expected to boost growth.Based on Region, North America is the most significant market for Antacids:
The North American antacids market is anticipated to grow significantly due to lifestyle changes and the rising geriatric population leading to gastrointestinal problems among the American people. Also, the trend towards self-medication in countries such as the United States is increasing the demand for OTC (over-the-counter) digestive products, such as antacids. As a result, antacids are the most common over-the-counter products in the United States.Impact of COVID-19 on Antacids market:
Market growth was hampered by declining production, a lockdown, and a labor shortage during the COVID-19 epidemic. As a result, the prices were higher than usual. But due to the rising demand for new antacids, the market will be growing in the coming years. Furthermore, the COVID-19 pandemic caused a transient spike in antacid sales, which led to panic buying among individuals who had severe medical conditions like gastroesophageal reflux disease and obesity. Additionally, it was witnessed that various gastrointestinal medications successfully enhanced the clinical results of hospitalized COVID-19 patients.Key Players:
Pfizer Inc, GlaxoSmithKline plc., Dr. Reddy's Laboratories Ltd, Johnson & Johnson, Bayer AG, Sanofi, and Abbott Laboratories, are the leading competitors in the Antacids industry. Further, these organizations employ various techniques to drive their company portfolio worldwide, including innovative product releases and R&D.The publisher's latest report “Antacids Market, Forecast By Drug Class (Proton Pump Inhibitor, H2 Antagonist, Acid Neutralizers), Dosage Form (Tablet, Liquid, Powder), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region ( North America, Europe, Asia Pacific,South America, Middle East & Africa), Companies (Pfizer Inc, GlaxoSmithKline plc., Dr Reddy's Laboratories Ltd, Johnson & Johnson, Bayer AG, Sanofi, Abbott Laboratories)” provides a detailed analysis of Global Antacids Market.
Drug Class - The market has been studied from 3 viewpoints:
1. Proton Pump Inhibitor2. H2 Antagonist
3. Acid Neutralizers
Dosage Form - The market has been studied from 3 viewpoints:
1. Tablet2. Liquid
3. Powder
Distribution Channel - The market has been studied from 3 viewpoints:
1. Hospital Pharmacies2. Retail Pharmacies
3. Online Pharmacies
By Region - The market has been studied from 5 viewpoints:
1. North America2. Europe
3. Asia Pacific
4. South America
5. Middle East & Africa
Company Insights:
- Overview
- Initiatives/Recent Developments
- Financial Insight
Companies Covered:
1. Pfizer Inc2. GlaxoSmithKline plc.
3. Dr Reddy's Laboratories Ltd
4. Johnson & Johnson
5. Bayer AG
6. Sanofi
7. Abbott Laboratories
Table of Contents
Companies Mentioned
- Pfizer Inc
- GlaxoSmithKline plc.
- Dr Reddy's Laboratories Ltd
- Johnson & Johnson
- Bayer AG
- Sanofi
- Abbott Laboratories
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
